| Authors: |
Redondo-Muñoz M; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Rodriguez-Baena FJ; Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain., Aldaz P; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Caballé-Mestres A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Moncho-Amor V; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Madrid, Spain., Otaegi-Ugartemendia M; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain., Carrasco-Garcia E; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Madrid, Spain., Olias-Arjona A; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Lasheras-Otero I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Santamaria E; Hepatology Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain., Bocanegra A; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Chocarro L; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Grier A; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Dzieciatkowska M M; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Bigas C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Martin J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Urdiroz-Urricelqui U; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Marzo F; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain., Santamaria E; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Clinical Neuroproteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Kochan G; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Escors D; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Larrayoz IM; Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, Logroño, Spain.; Unidad Predepartamental de Enfermería, Universidad de La Rioja (UR), Logroño, Spain., Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., D'Alessandro A; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Attolini CS; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Matheu A; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain., Wellbrock C; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Department of Health Sciences, Universidad Pública de Navarra (UPNA), Pamplona, Spain., Benitah SA; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org., Sanchez-Laorden B; Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain. berta.lopez@umh.es., Arozarena I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain. iarozarm@navarra.es.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain. iarozarm@navarra.es. |
